|Bid||115.22 x 2800|
|Ask||115.23 x 800|
|Day's Range||114.83 - 115.36|
|52 Week Range||102.07 - 121.24|
|PE Ratio (TTM)||-59.99|
|Expense Ratio (net)||0.20%|
In 2Q17, Orencia contributed around 13% of Bristol-Myers Squibb’s net revenues.
In 2Q17, Dentsply Sirona’s (XRAY) Technologies business contributed ~44% to the company’s total revenues and registered sales of ~$439 million.
In 2Q17, Amgen’s (AMGN) Kyprolis generated revenues of ~$211 million, which reflected ~23% growth on a YoY (year-over-year) basis and ~11% growth QoQ (quarter-over-quarter). In 2Q17, Kyprolis witnessed ...